FTC Issues Iterim Report on "Authorized Generic" Drugs
“The Federal Trade Commission today issued Authorized Generics: An Interim Report, which presents the first set of results from a study conducted to examine the short-term and long-term effects of authorized generics on competition in the prescription drug marketplace. An authorized generic exists when a pharmaceutical manufacturer sells a drug under both a brand-name and …